報價延遲最少15分鐘:2025/07/03 06:21 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
164.65 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
7.33/13.37
|
|
企業價值
41.14B
|
| 資產負債 |
|
每股賬面淨值
34.55
|
| 現金流量 |
|
現金流量率
0.09
|
| 損益表 |
|
收益
15.41B
|
|
每股收益
85.87
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/03 06:21 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business. |